Fate Therapeutics, Inc. (FATE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.28
Day's range
$1.38

Fate Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 08/14/2026 12.87 M $34.76 M   0.00% 10.72%
BLACKROCK, INC. 08/07/2026 7.30 M $19.71 M   -27.51% 6.08%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.55 M $12.27 M   9.95% 3.79%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.45 M $12.00 M   6.05% 3.70%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 4.35 M $11.74 M   5.61% 3.63%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 3.84 M $10.36 M   27.84% 3.20%
TWO SIGMA INVESTMENTS, LP 08/14/2026 3.59 M $9.69 M   3.55% 2.99%
JOHNSON & JOHNSON 08/06/2026 3.38 M $9.12 M   0.00% 2.82%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 2.98 M $8.05 M   0.29% 2.49%
MILLENNIUM MANAGEMENT LLC 08/14/2026 2.43 M $6.57 M   100.00% 2.03%
GOLDMAN SACHS GROUP INC 08/14/2026 2.05 M $5.53 M   54.33% 1.71%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.32 M $3.57 M   -48.97% 1.10%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 1.08 M $2.92 M   100.00% 0.90%
JANE STREET GROUP, LLC 08/14/2026 1.03 M $2.77 M   58.74% 0.86%
CITADEL ADVISORS LLC 08/14/2026 993.31 K $2.68 M   5.34% 0.83%
BRUCE & CO., INC. 08/14/2026 989.19 K $2.67 M   25.34% 0.82%
MORGAN STANLEY 08/13/2026 694.58 K $1.88 M   -9.53% 0.58%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 640.43 K $1.73 M   -2.04% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 610.95 K $1.65 M   -19.22% 0.51%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 610.95 K $1.65 M   100.00% 0.51%
UBS GROUP AG 08/13/2026 590.18 K $1.59 M   -67.60% 0.49%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 578.15 K $1.56 M   100.00% 0.48%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 575.00 K $1.55 M   22.40% 0.48%
STATE STREET CORP 08/07/2026 558.93 K $1.51 M   -75.30% 0.47%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2026 525.00 K $1.42 M   -4.55% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 511.05 K $1.38 M   71.21% 0.43%
MARSHALL WACE, LLP 08/13/2026 492.43 K $1.33 M   100.00% 0.41%
IEQ CAPITAL, LLC 08/11/2026 487.73 K $1.32 M   50.17% 0.41%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 442.23 K $1.19 M   925.60% 0.37%
PRIVIUM FUND MANAGEMENT B.V. 08/07/2026 414.31 K $1.12 M   0.00% 0.35%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 352.23 K $949.09 K   -60.15% 0.29%
CERITY PARTNERS LLC 08/14/2026 341.73 K $854.03 K   200.97% 0.28%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 338.06 K $912.76 K   100.00% 0.28%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 271.63 K $733.41 K   956.33% 0.23%
INVESCO LTD. 08/14/2026 265.98 K $718.15 K   -29.24% 0.22%
HEADLANDS TECHNOLOGIES LLC 08/13/2026 251.80 K $679.87 K   100.31% 0.21%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 245.81 K $663.70 K   100.00% 0.20%
NORTHERN TRUST CORP 08/13/2026 242.67 K $655.21 K   -70.11% 0.20%
HSBC HOLDINGS PLC 08/14/2026 240.72 K $635.51 K   146.43% 0.20%
LPL FINANCIAL LLC 08/07/2026 203.75 K $550.11 K   37.90% 0.17%
MARINER, LLC 08/13/2026 192.22 K $518.76 K   95.55% 0.16%
BARCLAYS PLC 08/14/2026 187.99 K $507.57 K   157.53% 0.16%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 185.00 K $499.50 K   0.00% 0.15%
XTX TOPCO LTD 08/14/2026 180.83 K $488.23 K   -53.54% 0.15%
ASTER CAPITAL MANAGEMENT (DIFC) LTD 08/14/2026 176.60 K $476.82 K   100.00% 0.15%
MAN GROUP PLC 08/14/2026 176.11 K $475.49 K   -59.05% 0.15%
WOODLINE PARTNERS LP 08/14/2026 159.65 K $431.06 K   -33.10% 0.13%
BANK OF AMERICA CORP /DE/ 08/14/2026 153.71 K $415.01 K   -18.49% 0.13%
SQUAREPOINT OPS LLC 08/14/2026 153.62 K $414.79 K   100.00% 0.13%
ARETE WEALTH ADVISORS, LLC 08/13/2026 150.00 K $405.00 K   100.00% 0.13%

Fate Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 258 institutional investors and hedge funds held shares of Fate Therapeutics Inc. The most heavily invested institutionals were:

Redmile Group, LLC: 12.87 M

BlackRock, Inc.: 7.3 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 4.55 M

VANGUARD CAPITAL MANAGEMENT LLC: 4.45 M

ACADIAN ASSET MANAGEMENT LLC: 4.35 M

AQR CAPITAL MANAGEMENT LLC: 3.84 M

60.12% of Fate Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 107.02 M shares in the last 24 months. This purchase volume represents approximately $142.34 M in transactions.